220 related articles for article (PubMed ID: 23873831)
1. Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis.
Mignon I; Grand F; Boyer F; Hunault-Berger M; Hamel JF; Macchi L
Am J Hematol; 2013 Dec; 88(12):1007-11. PubMed ID: 23873831
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.
Marchetti M; Tartari CJ; Russo L; Panova-Noeva M; Leuzzi A; Rambaldi A; Finazzi G; Woodhams B; Falanga A
Am J Hematol; 2014 Jan; 89(1):68-73. PubMed ID: 24009132
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.
Duchemin J; Ugo V; Ianotto JC; Lecucq L; Mercier B; Abgrall JF
Thromb Res; 2010 Sep; 126(3):238-42. PubMed ID: 20656333
[TBL] [Abstract][Full Text] [Related]
4. Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera.
Panova-Noeva M; Marchetti M; Spronk HM; Russo L; Diani E; Finazzi G; Salmoiraghi S; Rambaldi A; Barbui T; Ten Cate H; Falanga A
Am J Hematol; 2011 Apr; 86(4):337-42. PubMed ID: 21442635
[TBL] [Abstract][Full Text] [Related]
5. Polymorphonuclear neutrophils from JAK2(V617F) positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT).
Perrin J; Ranta D; Empereur F; Vigneron C; Feugier P; Lecompte T
Blood Cells Mol Dis; 2011 Mar; 46(3):235-8. PubMed ID: 21306925
[TBL] [Abstract][Full Text] [Related]
6. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays.
Noubouossie DC; Lê PQ; Rozen L; Debaugnies F; Ferster A; Demulder A
Thromb Res; 2012 Aug; 130(2):259-64. PubMed ID: 22079446
[TBL] [Abstract][Full Text] [Related]
8. Assessment of procoagulant potential in patients with reactive thrombocytosis and its association with platelet count.
Rottenstreich A; Shai E; Kleinstern G; Spectre G; Varon D; Kalish Y
Eur J Haematol; 2018 Mar; 100(3):286-293. PubMed ID: 29240268
[TBL] [Abstract][Full Text] [Related]
9. Characteristic changes in platelet-large cell ratio, lactate dehydrogenase and C-reactive protein in thrombocytosis-related diseases.
Kabutomori O; Kanakura Y; Iwatani Y
Acta Haematol; 2007; 118(2):84-7. PubMed ID: 17622783
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of the relevance of thrombin generation and procoagulant activity in thrombotic risk assessment in BCR-ABL-negative myeloproliferative neoplasm patients.
Baccouche H; Ben Jemaa M; Chakroun A; Chadi S; Mahjoub S; Sfar I; Gorgi Y; Ben Romdhane N
Int J Lab Hematol; 2017 Oct; 39(5):502-507. PubMed ID: 28497580
[TBL] [Abstract][Full Text] [Related]
11. Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure.
Van Dreden P; Woodhams B; Rousseau A; Dreyfus JF; Vasse M
Clin Chem Lab Med; 2013 Feb; 51(2):387-96. PubMed ID: 23096108
[TBL] [Abstract][Full Text] [Related]
12. Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation.
van Genderen PJ; Lucas IS; van Strik R; Vuzevski VD; Prins FJ; van Vliet HH; Michiels JJ
Thromb Haemost; 1996 Sep; 76(3):333-8. PubMed ID: 8883266
[TBL] [Abstract][Full Text] [Related]
13. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.
Arellano-Rodrigo E; Alvarez-Larrán A; Reverter JC; Colomer D; Villamor N; Bellosillo B; Cervantes F
Am J Hematol; 2009 Feb; 84(2):102-8. PubMed ID: 19105233
[TBL] [Abstract][Full Text] [Related]
14. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
Brière J
Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
[TBL] [Abstract][Full Text] [Related]
15. Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2(V617F) mutational status.
Ohyashiki K; Akahane D; Gotoh A; Ito Y; Tauchi T; Miyazawa K; Kimura Y; Ohyashiki JH
Leukemia; 2007 Dec; 21(12):2544-5. PubMed ID: 17611562
[No Abstract] [Full Text] [Related]
16. Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity.
Mina A; Favaloro EJ; Koutts J
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):203-7. PubMed ID: 22322136
[TBL] [Abstract][Full Text] [Related]
17. VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia.
Silveira A; Carlo A; Adam M; McLeod O; Lundman P; Boquist S; Woodhams BJ; Hamsten A
Int J Lab Hematol; 2018 Jun; 40(3):251-257. PubMed ID: 29356352
[TBL] [Abstract][Full Text] [Related]
18. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytosis and thrombocythemia: qualitative platelet abnormalities.
Okuma M
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1265-72. PubMed ID: 2629455
[TBL] [Abstract][Full Text] [Related]
20. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.
Trappenburg MC; van Schilfgaarde M; Marchetti M; Spronk HM; ten Cate H; Leyte A; Terpstra WE; Falanga A
Haematologica; 2009 Jul; 94(7):911-8. PubMed ID: 19508974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
